BGA Stock Overview
Engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products, with a focus on oligosaccharides. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
BioNeutra Global Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.03 |
| 52 Week High | CA$0.16 |
| 52 Week Low | CA$0.015 |
| Beta | 1.51 |
| 1 Month Change | 0% |
| 3 Month Change | -40.00% |
| 1 Year Change | 50.00% |
| 3 Year Change | -82.35% |
| 5 Year Change | -90.00% |
| Change since IPO | -93.33% |
Recent News & Updates
Recent updates
Calculating The Fair Value Of BioNeutra Global Corporation (CVE:BGA)
Dec 30
A Look At The Fair Value Of BioNeutra Global Corporation (CVE:BGA)
Aug 24We Discuss Why BioNeutra Global Corporation's (CVE:BGA) CEO Compensation May Be Closely Reviewed
Sep 15Is BioNeutra Global (CVE:BGA) Using Too Much Debt?
Jul 12Is BioNeutra Global (CVE:BGA) Weighed On By Its Debt Load?
Mar 29Does BioNeutra Global (CVE:BGA) Have A Healthy Balance Sheet?
Dec 14Shareholder Returns
| BGA | CA Food | CA Market | |
|---|---|---|---|
| 7D | 0% | -3.3% | -2.6% |
| 1Y | 50.0% | -5.6% | 15.2% |
Return vs Industry: BGA exceeded the Canadian Food industry which returned -5.6% over the past year.
Return vs Market: BGA exceeded the Canadian Market which returned 15.2% over the past year.
Price Volatility
| BGA volatility | |
|---|---|
| BGA Average Weekly Movement | n/a |
| Food Industry Average Movement | 3.7% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CA Market | 17.4% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: BGA's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine BGA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Jianhua Zhu | www.bioneutra.ca |
BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products, with a focus on oligosaccharides. The company offers isomaltooligosaccharide ingredients under the VitaFiber brand, that provides low calorie soluble prebiotic fiber for human digestive health. It serves small and medium enterprises, and various food manufacturers through direct-to-consumer retail channels, as well as through online retailers in Canada, the United States, Australia, New Zealand, European Union, and the Asia Pacific.
BioNeutra Global Corporation Fundamentals Summary
| BGA fundamental statistics | |
|---|---|
| Market cap | CA$1.39m |
| Earnings (TTM) | -CA$610.20k |
| Revenue (TTM) | CA$10.86m |
0.1x
P/S Ratio-2.3x
P/E RatioIs BGA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BGA income statement (TTM) | |
|---|---|
| Revenue | CA$10.86m |
| Cost of Revenue | CA$6.21m |
| Gross Profit | CA$4.65m |
| Other Expenses | CA$5.26m |
| Earnings | -CA$610.20k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.013 |
| Gross Margin | 42.85% |
| Net Profit Margin | -5.62% |
| Debt/Equity Ratio | -91.1% |
How did BGA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 04:48 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
BioNeutra Global Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|